FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

38067411000001101: Rinvoq 15mg modified-release tablets (AbbVie Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Feb 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1160621000001113 Rinvoq 15mg modified-release tablets (AbbVie Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1160641000001115 Rinvoq 15mg modified-release tablets (AbbVie Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rinvoq 15mg modified-release tablets (AbbVie Ltd) Has specific active ingredient Upadacitinib hemihydrate true Inferred relationship Existential restriction modifier
Rinvoq 15mg modified-release tablets (AbbVie Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rinvoq 15mg modified-release tablets (AbbVie Ltd) Is a Upadacitinib 15mg modified-release tablets true Inferred relationship Existential restriction modifier
Rinvoq 15mg modified-release tablets (AbbVie Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Rinvoq 15mg modified-release tablets (AbbVie Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rinvoq 15mg modified-release tablets (AbbVie Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Rinvoq 15mg modified-release tablets (AbbVie Ltd) Is a Rinvoq true Inferred relationship Existential restriction modifier
Rinvoq 15mg modified-release tablets (AbbVie Ltd) Has specific active ingredient Upadacitinib hemihydrate false Inferred relationship Existential restriction modifier
Rinvoq 15mg modified-release tablets (AbbVie Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rinvoq 15mg modified-release tablets (AbbVie Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Upadacitinib false Inferred relationship Existential restriction modifier
Rinvoq 15mg modified-release tablets (AbbVie Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rinvoq 15mg modified-release tablets (AbbVie Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rinvoq 15mg modified-release tablets (AbbVie Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Rinvoq 15mg modified-release tablets (AbbVie Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Upadacitinib false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Rinvoq 15mg modified-release tablets (AbbVie Ltd) 28 tablet 4 x 7 tablets Has AMP True Rinvoq 15mg modified-release tablets (AbbVie Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start